Home / Denmark / Zealand Pharma A/S
Zealand Pharma A/S
Short position disclosed on May 29, 2026.
6.75% of the capital sold short
8 disclosing funds
454 disclosures on record
DK0060257814 ISIN code
Evolution of the disclosed total
0%2%4%6%8%
Oct 2025Jan 2026Apr 2026Jul 2026
March 31, 2015 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Marshall Wace LLP | 1.29% | new | May 26, 2026 | |
| Voleon Capital Management LP | 1.11% | new | May 19, 2026 | |
| AHL Partners LLP | 0.91% | new | May 7, 2026 | |
| Citadel Advisors LLC | 0.83% | new | May 29, 2026 | |
| Connor Clark & Lunn Investment Management Ltd | 0.80% | new | April 28, 2026 | |
| Jupiter Asset Management Limited | 0.70% | new | March 12, 2026 | |
| Jennison Associates LLC | 0.61% | new | April 13, 2026 | |
| D. E. Shaw & Co., L.P. | 0.50% | new | May 11, 2026 |
On the other side: the funds that hold Zealand Pharma A/S Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| May 7, 2015 | GSA Capital Partners LLP | 0.61% | May 7, 2015 |
| April 17, 2015 | GSA Capital Partners LLP | 0.51% | April 17, 2015 |
| April 8, 2015 | GSA Capital Partners LLP | 0.49% | April 8, 2015 |
| March 31, 2015 | GSA Capital Partners LLP | 0.50% | March 31, 2015 |
Other companies sold short in Denmark
- GN Store Nord A/S 4.81% of the capital sold short
- Ambu A/S 4.00% of the capital sold short
- Pandora A/S 2.25% of the capital sold short
- Carlsberg A/S 1.90% of the capital sold short
- Demant A/S 1.89% of the capital sold short
- Netcompany Group A/S 1.58% of the capital sold short
- Aquaporin A/S 1.51% of the capital sold short
- Matas A/S 1.28% of the capital sold short
- Noble Corporation Plc 1.17% of the capital sold short
- Novozymes A/S 1.00% of the capital sold short
- ChemoMetec A/S 0.92% of the capital sold short
- Coloplast A/S 0.79% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Zealand Pharma A/S, source Finanstilsynet, data as at May 29, 2026, https://www.quivad.com/action/zealand-pharma-a-s?page=10